| Literature DB >> 33560660 |
Ksenia Vlasov1,2, JunZhu Pei1,2, Christa J Nehs1,2,3, Jennifer A Guidera1, Edlyn R Zhang1, Jonathan D Kenny4, Timothy T Houle1,3, Gary J Brenner1,3, Norman E Taylor5, Ken Solt1,2,3.
Abstract
Many general anesthetics potentiate gamma-aminobutyric acid (GABA) A receptors but their neuroanatomic sites of action are less clear. GABAergic neurons in the rostromedial tegmental nucleus (RMTg) send inhibitory projections to multiple arousal-promoting nuclei, but the role of these neurons in modulating consciousness is unknown. In this study, designer receptors exclusively activated by designer drugs (DREADDs) were targeted to RMTg GABAergic neurons of Vgat-ires-Cre mice. DREADDs expression was found in the RMTg and other brainstem regions. Activation of these neurons decreased movement and exploratory behavior, impaired motor coordination, induced electroencephalogram (EEG) oscillations resembling nonrapid eye movement (NREM) sleep without loss of righting and reduced the dose requirement for sevoflurane-induced unconsciousness. These results suggest that GABAergic neurons in the RMTg and other brainstem regions promote sedation and facilitate sevoflurane-induced unconsciousness.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33560660 PMCID: PMC7969415 DOI: 10.1213/ANE.0000000000005387
Source DB: PubMed Journal: Anesth Analg ISSN: 0003-2999 Impact factor: 6.627